Inhibition of measles virus multiplication in cell culture by RNA interference

Acta Virologica

Volumn 49, Issue 4, 2005, Pages 227-234

  Hu, L ^a   Wang, Z ^a   Hu, C ^a   Liu, X ^a   Yao, L ^a   Li, W ^a   Qi, Y ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

B95 8 cell line; Measles virus; RNAi; siRNAs; SLAM

Indexed keywords

CD150 ANTIGEN; VIRUS VECTOR; CELL SURFACE RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; SMALL INTERFERING RNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE CONTROL; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEASLES; MEASLES VIRUS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM; VIROGENESIS; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CERCOPITHECUS; GENETICS; GROWTH, DEVELOPMENT AND AGING; MARMOSET; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; VERO CELL;

HUMAN HERPESVIRUS 4; MARMOSETS; MEASLES VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CALLITHRIX; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; GLYCOPROTEINS; IMMUNOGLOBULINS; MEASLES VIRUS; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSFECTION; VERO CELLS; VIRUS REPLICATION;

EID: 33645998463     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ahlquist P (2002): RNA-dependent RNA polymerases, viruses, and RNA silencing. Science 296, 1270-1273.
2. Aversa G, Chang CC, Carballido JM, Cocks BG, de Vries JE (1997): Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J. Immunol. 158, 4036-4044.
3. Brummelkamp TR, Bernards R, Agami R (2002): Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247.
4. Caplen NJ, Taylor JP, Statham VS, Tanaka F, Fire A, Morgan RA (2002): Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum. Mol. Genet. 11, 175-184.
5. Centers for Disease Control and Prevention (1999): Global measles control and regional elimination, 1998-1999. Morb. Mortal. Weekly Rep. 48, 1124-1130.
6. Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G (1995): A novel receptor involved in T-cell activation. Nature 376, 260-263.
7. Dorig RE, Marcil A, Chopra A, Richardson CD (1993): The human CD46 molecule is a receptor for measles virus (Edmons-ton strain). Cell 75, 295-305.
8. David J, Shuey, Daniel E, McCallus, Tony Giordano (2002): RNAi: gene-silencing in therapeutic intervention. Ther. Focus 7, 1040-1046.
9. Elbashir SM, Lendeckel W, Tuschl T (2001): RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15, 188-200.
10. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998): Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
11. Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K (2003): Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Letters 543, 51-54.
12. Hammond SM, Bernstein E, Beach D, Hannon GJ. Genetica, Inc. (2000): An RNA-directed nuclease mediates posttranscriptional gene silencing in Drosophila cells. Nature 404, 293-296.
13. Harborth J, Elbashir SM, Vandenburgh K, Manninga H, Scaringe SA, Weber K, Tuschl T (2003): Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13, 83-105.
14. Hutvagner G, Zamore PD (2002): RNAi: nature abhors a double-strand. Curr. Opin. Genet. Dev. 12, 225-232.
15. Klagge IM, Schneider-Schaulies S (1999): Virus interactions with dendritic cells. J. Gen. Virol. 80, 823-833.
16. Kobune F, Sakata H, Sugiura A (1990): Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64, 700-705.
17. Kretschmer-Kazemi Far R, Sczakiel G (2003): The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res. 31, 4417-4424.
18. Kruse M, Meinl E, Henning G, Kuhnt C, Berchtold S, Berger T, Schuler G, Steinkasserer A (2001): Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta. J. Immunol. 167, 1989-1995.
19. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J (2002): Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20, 500-505.
20. Naniche D, Wild TF, Rabourdin-Combe C, Gerlier D (1993): Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. J. Gen. Virol. 74, 1073-1079.
21. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P, Sharp PA (2002): siRNA-directed inhibition of HIV-1 infection. Nat. Med. 18, 681-686.
22. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y (2001): Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDwl50) but not CD46 as a cellular receptor. J. Virol. 75, 4399-4401.
23. Plemper RK, Erlandson KJ, Lakdawala AS, Sun A, Prussia A, Boonsombat J, Aki-Sener E, Yalcin I, Yildiz I, Temiz-Arpaci O, Tekiner B, Liotta DC, Snyder JP, Compans RWA (2004): Target site for template-based design of measles virus entry inhibitors. Proc. Natl. Acad. Sci. USA 101, 5628-5633.
24. Qin XF, An DS, Chen IS, Baltimore D (2003): Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA 100, 183-188.
25. Rota JS, Health JL, Rota PA, King GE, Celma M, Carabana J, Fernandez-Munoz R, Brown D, Jin L, Bellini WJ (1996): Molecular epidemiology of measles virus: identification of pathways of transmission and implication for measles elimination. J. Infect. Dis. 173, 32-37.
26. Saghir A, Marcus DH, Alim K, Mike B, Majad H, Qamar N, John D, Pakeeza S (2000): The delivery of antisense therapeutics. Adv. Drug Delivery Rev. 44, 3-21.
27. Schutze N. (2004): siRNA technology. Mol. Cell. Endocrinol. 213, 115-119.
28. Shuey DJ, McCallus DE, Giordano T (2002): RNAi: gene-silencing in therapeutic intervention. Drug Discov. Today 15, 1040-1046.
29. Sidorenko SP, Clark EA (1993): Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol. 151, 4614-4624.
30. Takeda M, Takeuchi K, Miyajima N, Kobune F, Ami Y, Nagata N, Suzaki Y, Nagai Y, Tashiro M (2000): Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74, 6643-6647.
31. Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000): SLAM (CDwl50) is a cellular receptor for measles virus. Nature 406, 893-897.
32. Vickers TA, Koo S, Bennett CF, Crooke ST, Dean NM, Baker BF (2003): Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278, 7108-7118
33. Yanagi Y, Ono N, Tatsuo H, Hashimoto K, Minagawa H (2002): Measles Virus Receptor SLAM (CD150). Virology 299, 155-161
34. Zamore PD, Tuschl T, Sharp PA, Bartel DP (2000): RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101, 25-33.
35. Zhang H, Cook J, Nickel J, Yu R, Stecker K, Myers K, Dean NM (2000): Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat. Biotechnol. 18, 862-867.